Last reviewed · How we verify
NCT03802149: U-Prep
Ulipristal Acetate for Cervical Preparation
EARLY_PHASE1 trial testing Ulipristal Acetate in Termination of Pregnancy in 13 participants. Completed in 2 April 2020.
2 April 2020
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 13 |
| Start date | 16 April 2019 |
| Primary completion | 2 April 2020 |
| Estimated completion | 2 April 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Ulipristal Acetate — full drug profile →
Conditions studied
- Termination of Pregnancy — all drugs for Termination of Pregnancy →
Sponsor
Stanford University
Who can join
18 and older, female only, with Termination of Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective cohort study exploring a broadened use of ulipristal acetate as a cervical preparation agent for second trimester surgical abortion. Specifically, this pilot study will test the feasibility of using ulipristal as a pharmacologic cervical preparation with adjunct misoprostol prior to surgical abortion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03802149
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ulipristal Acetate
Trials testing the same drug.
- NCT07434128 — Mammogram Pretreatment With Ulipristal Acetate · Phase 2 · not yet recruiting
- NCT05285605 — Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy · completed
- NCT04004884 — Liver Safety Assessment During Ulipristal Acetate Treatment for Uterine Fibroids (LISA) · terminated
- NCT04989400 — Use of Ulipristal Acetate in Induction of Second Trimester Missed Abortion · Phase 4 · completed
- NCT03537768 — Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg · Phase 4 · terminated
Other recruiting trials for Termination of Pregnancy
Currently open trials in the same condition.
- NCT06708208 — Requests for Voluntary Termination and Medical Termination of Pregnancy for Maternal, Psychological or Social Reasons At · active not recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03802149 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 1 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03802149.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing